Efficacy and basic safety involving PD-1/PD-L1 plus CTLA-4 antibodies

alleyheight20 4 6th Nov, 2024

HTML 2.00 KB

copy share raw download clone embed report print

Loading Please wait...

Description

No description

To share this paste please copy this url and send to your friends

RAW Paste Data